These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21414249)

  • 1. Evidence-based pharmacotherapy of eating disorders.
    Flament MF; Bissada H; Spettigue W
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):189-207. PubMed ID: 21414249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy for patients with eating disorders.
    Mitchell JE; de Zwaan M; Roerig JL
    Curr Drug Targets CNS Neurol Disord; 2003 Feb; 2(1):17-29. PubMed ID: 12769809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of selective serotonin reuptake inhibitors in eating disorders.
    Mayer LE; Walsh BT
    J Clin Psychiatry; 1998; 59 Suppl 15():28-34. PubMed ID: 9786308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current pharmacotherapy options for bulimia nervosa and binge eating disorder.
    McElroy SL; Guerdjikova AI; Mori N; O'Melia AM
    Expert Opin Pharmacother; 2012 Oct; 13(14):2015-26. PubMed ID: 22946772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the pharmacotherapy of eating disorders.
    Pederson KJ; Roerig JL; Mitchell JE
    Expert Opin Pharmacother; 2003 Oct; 4(10):1659-78. PubMed ID: 14521477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies for eating disorders.
    Mitchell JE; Roerig J; Steffen K
    Int J Eat Disord; 2013 Jul; 46(5):470-7. PubMed ID: 23658094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
    Aigner M; Treasure J; Kaye W; Kasper S;
    World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials.
    Fornaro M; Mondin AM; Billeci M; Fusco A; De Prisco M; Caiazza C; Micanti F; Calati R; Carvalho AF; de Bartolomeis A
    J Affect Disord; 2023 Oct; 338():526-545. PubMed ID: 37393954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotherapy and Medications for Eating Disorders: Better Together?
    Reas DL; Grilo CM
    Clin Ther; 2021 Jan; 43(1):17-39. PubMed ID: 33342555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences.
    Himmerich H; Kan C; Au K; Treasure J
    Pharmacol Ther; 2021 Jan; 217():107667. PubMed ID: 32858054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for eating disorder treatment.
    Steffen KJ; Roerig JL; Mitchell JE; Uppala S
    Expert Opin Emerg Drugs; 2006 May; 11(2):315-36. PubMed ID: 16634704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of eating disorders.
    Davis H; Attia E
    Curr Opin Psychiatry; 2017 Nov; 30(6):452-457. PubMed ID: 28806268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses.
    Monteleone AM; Pellegrino F; Croatto G; Carfagno M; Hilbert A; Treasure J; Wade T; Bulik CM; Zipfel S; Hay P; Schmidt U; Castellini G; Favaro A; Fernandez-Aranda F; Il Shin J; Voderholzer U; Ricca V; Moretti D; Busatta D; Abbate-Daga G; Ciullini F; Cascino G; Monaco F; Correll CU; Solmi M
    Neurosci Biobehav Rev; 2022 Nov; 142():104857. PubMed ID: 36084848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical psychopharmacology of eating disorders: a research update.
    Hay PJ; Claudino AM
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):209-22. PubMed ID: 21439105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eating disorders, serotonin transporter polymorphisms and potential treatment response.
    Gorwood P
    Am J Pharmacogenomics; 2004; 4(1):9-17. PubMed ID: 14987118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of eating disorders.
    Berkman ND; Bulik CM; Brownley KA; Lohr KN; Sedway JA; Rooks A; Gartlehner G
    Evid Rep Technol Assess (Full Rep); 2006 Apr; (135):1-166. PubMed ID: 17628126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for eating disorders and obesity.
    Powers PS; Bruty H
    Child Adolesc Psychiatr Clin N Am; 2009 Jan; 18(1):175-87. PubMed ID: 19014865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.
    Krüger S; Kennedy SH
    J Psychiatry Neurosci; 2000 Nov; 25(5):497-508. PubMed ID: 11109300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.
    McElroy SL; Guerdjikova AI; Mori N; Romo-Nava F
    CNS Drugs; 2019 Jan; 33(1):31-46. PubMed ID: 30523523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy for anorexia nervosa and bulimia nervosa].
    Greetfeld M; Cuntz U; Voderholzer U
    Fortschr Neurol Psychiatr; 2012 Jan; 80(1):9-16. PubMed ID: 22161227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.